Clinical Efficacy and Safety of Combination Therapy with Amlodipine and Olmesartan or an Olmesartan/Hydrochlorothiazide Compound for Hypertension: A Prospective, Open-Label, and Multicenter Clinical Trial in China

BACKGROUND: Amlodipine (AML) is the initial therapy most commonly prescribed for patients with hypertension in China. However, AML monotherapy is often less effective in achieving blood pressure (BP) control than other agents. OBJECTIVE: We performed a clinical study to evaluate efficacy and safety...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Curr Ther Res Clin Exp
Main Authors: Gao, Pingjin, Mei, Kezhi, Li, Hongwei, Dai, Qiuyan, Guo, Xingui, Zhang, Daifu, Jin, Zhimin, You, Hua, Ding, Hong, Lü, Ke, Zhou, Shuxian, Peng, Xiaoling, Xu, Hui, Yin, Pengfei, Yu, Licheng, Pi, Lin, Hua, Qi, Yang, Ming, Yu, Xiaowei
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2015
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6677643/
https://ncbi.nlm.nih.gov/pubmed/31388362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.curtheres.2015.09.001
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares